Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
International Journal of Nanomedicine
|
November 5, 2021
Gold Nanostars: A Novel Platform for Developing <sup>211</sup>At-Labeled Agents for Targeted Alpha-Particle Therapy
Yang Liu, Zhengyuan Zhou, Yutian Feng, et al.
Microbiology Resource Announcements
|
April 3, 2019
Complete Genome Sequence of Halorubrum ezzemoulense Strain Fb21
Yutian Feng, Artemis S Louyakis, Andrea M Makkay, et al.
Mbio
|
April 15, 2024
Using the pan-genomic framework for the discovery of genomic islands in the haloarchaeon <i>Halorubrum ezzemoulense</i>
Yutian Feng, Danielle Arsenault, Artemis S Louyakis, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 30, 2025
Effective treatment of human prostate carcinoma xenografts with Single-Dose PSMA-targeted [<sup>211</sup>At]YF2
Yutian Feng, Truc T Huynh, Yongxiang Zheng, et al.
Nuclear Medicine and Biology
|
May 4, 2024
PSMA-reactive NB7 single domain antibody fragment: A potential scaffold for developing prostate cancer theranostics
Truc T Huynh, Yutian Feng, Rebecca Meshaw, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 10, 2026
First-in-human evaluation of [<sup>211</sup>At]YF2 in patients with metastatic castration-resistant prostate cancer
Xiaoai Wu, Yongzhao Xiang, Michael R Zalutsky, et al.
Journal of Medicinal Chemistry
|
November 11, 2022
Site-Specific Radiohalogenation of a HER2-Targeted Single-Domain Antibody Fragment Using a Novel Residualizing Prosthetic Agent
Yutian Feng, Samantha M Sarrett, Rebecca L Meshaw, et al.
Nuclear Medicine and Biology
|
May 4, 2024
A third generation PSMA-targeted agent [<sup>211</sup>At]YF2: Synthesis and in vivo evaluation
Yutian Feng, Rebecca L Meshaw, Sean W Finch, et al.
Exploration (Beijing, China)
|
March 5, 2025
Bioactive scaffolds for tissue engineering: A review of decellularized extracellular matrix applications and innovations
Juan Liu, Qingru Song, Wenzhen Yin, et al.
Molecular Pharmaceutics
|
June 8, 2026
Synthesis and Preliminary Evaluation of the <sup>211</sup>At-Labeled PARP Inhibitor [<sup>211</sup>At]Talazoparib as a Targeted Alpha-Particle Emitting Therapeutic
Yongxiang Zheng, Deyu Kong, Truc T Huynh, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
International Journal of Nanomedicine
|
November 5, 2021
Gold Nanostars: A Novel Platform for Developing <sup>211</sup>At-Labeled Agents for Targeted Alpha-Particle Therapy
Yang Liu, Zhengyuan Zhou, Yutian Feng, et al.
Microbiology Resource Announcements
|
April 3, 2019
Complete Genome Sequence of Halorubrum ezzemoulense Strain Fb21
Yutian Feng, Artemis S Louyakis, Andrea M Makkay, et al.
Mbio
|
April 15, 2024
Using the pan-genomic framework for the discovery of genomic islands in the haloarchaeon <i>Halorubrum ezzemoulense</i>
Yutian Feng, Danielle Arsenault, Artemis S Louyakis, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 30, 2025
Effective treatment of human prostate carcinoma xenografts with Single-Dose PSMA-targeted [<sup>211</sup>At]YF2
Yutian Feng, Truc T Huynh, Yongxiang Zheng, et al.
Nuclear Medicine and Biology
|
May 4, 2024
PSMA-reactive NB7 single domain antibody fragment: A potential scaffold for developing prostate cancer theranostics
Truc T Huynh, Yutian Feng, Rebecca Meshaw, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 10, 2026
First-in-human evaluation of [<sup>211</sup>At]YF2 in patients with metastatic castration-resistant prostate cancer
Xiaoai Wu, Yongzhao Xiang, Michael R Zalutsky, et al.
Journal of Medicinal Chemistry
|
November 11, 2022
Site-Specific Radiohalogenation of a HER2-Targeted Single-Domain Antibody Fragment Using a Novel Residualizing Prosthetic Agent
Yutian Feng, Samantha M Sarrett, Rebecca L Meshaw, et al.
Nuclear Medicine and Biology
|
May 4, 2024
A third generation PSMA-targeted agent [<sup>211</sup>At]YF2: Synthesis and in vivo evaluation
Yutian Feng, Rebecca L Meshaw, Sean W Finch, et al.
Exploration (Beijing, China)
|
March 5, 2025
Bioactive scaffolds for tissue engineering: A review of decellularized extracellular matrix applications and innovations
Juan Liu, Qingru Song, Wenzhen Yin, et al.
Molecular Pharmaceutics
|
June 8, 2026
Synthesis and Preliminary Evaluation of the <sup>211</sup>At-Labeled PARP Inhibitor [<sup>211</sup>At]Talazoparib as a Targeted Alpha-Particle Emitting Therapeutic
Yongxiang Zheng, Deyu Kong, Truc T Huynh, et al.
Page
of 4